No abstract available
MeSH terms
-
Anticoagulants / standards
-
Anticoagulants / therapeutic use*
-
Bias
-
Case Management
-
Clinical Trials, Phase III as Topic / methods
-
Clinical Trials, Phase III as Topic / standards
-
Cost-Benefit Analysis
-
Double-Blind Method*
-
Fibrinolytic Agents / standards
-
Fibrinolytic Agents / therapeutic use
-
Heparin / therapeutic use
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Patient Selection
-
Professional Practice
-
Prothrombin Time / instrumentation
-
Quality of Life
-
Randomized Controlled Trials as Topic / methods*
-
Randomized Controlled Trials as Topic / standards
-
Thrombophilia / drug therapy
-
Treatment Outcome
-
Vitamin K / antagonists & inhibitors
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Heparin, Low-Molecular-Weight
-
Vitamin K
-
Heparin